Industry Analysis: Pharma

Presented By:-

Neeraj Goswami

Prerna Agarwal

Ojaswi Katiyar

“The Indian pharmaceutical industry is a success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent.” Richard Gerster

Contents

1) Overview of Indian pharma.2) Evolution of Indian Pharma.3) Major players.4) Drug Trial.5) Medical tourism.6) Moving up to the value chain.7) Pharmaceutical-association in India.8) Future scenario.9) Pharma in news.

Indian Pharmaceutical Evolution

Phase II

Government Control•Indian Patent Act –1970•Drug prices capped•Local companies begin to make an impact

Phase III Development Phase

•Process development

•Production infrastructure creation

•Export initiatives

Phase IV

Growth Phase

•Rapid expansion of domestic market

•International market development

•Research orientation

Phase V

Innovation and Research•New IP law•Discovery Research •Convergence

1970 1980 1990 2000 2010

Phase I

Early Years•Market share domination by foreign companies•Relative absence of organized Indian companies

Drug Trial

• Phase-1• Phase-2• Phase-3• Phase-4Benefits:-• Play an active role in their own health care.• Gain access to new research treatments before they are widely available. • Obtain expert medical care at leading health care facilities during the trial.• Help others by contributing to medical research.

Risks:-• There may be unpleasant, serious or even life-threatening side effects

to experimental treatment.• The experimental treatment may not be effective for the participant.

Medical Tourism• Cheaper medical and relaxation needs. • Excellent infrastructure and technology in which is in

par with those in USA, UK and Europe.• Some treatments which are best in India are:-

Eye Care Dental Care IVF Treatment Heart Surgery & Heart Care Health Check Up Cosmetic Treatment Orthopedic Surgery

Moving up the Value Chain

Specialty Products

Innovative Products

TIME

Generic exports to under-

developed & developing countries

Generic exports to developed countries

API Exports

VALUE

Pharmaceutical Associations In India IDMA CIPI-SSI

OPPI IPA

BDMA APTI

Indian Pharma Industry – Future Scenario

• The Indian pharma industry is still trying to come to terms with the new patent regime.

• Over the next 5 years, will continue to grow by at least twice the rate of global growth.

• Retail segment will be the fastest growing segment.

• There will be a significant increase in the clinical trials and diagnostics outsourcing.

• A significant window of opportunity will be available expiring patents.

Pharma in News

• August 20, 2008: 49 babies die at leading hospitals under drug trail process.

• Fight between Ranbaxy and Pfizer.(Lipitor)

• H1N1 vaccination available in Indian Pharmaceutical market. (Nasovac)

• Aurobindo pharma and Astra-Zeneca to jointly supply solid dosage in emerging market.

Biblograpahy

• www.pharmainfo.net• www.fairdrugs.org• www.ipapharma.org• www.pharmabiz.com• www.pharmaceutical

-drug-manufacturers.com• www.medindia.net

Thank you….!

Any queries ?